Stock Traders Purchase High Volume of Call Options on Oscar Health (NYSE:OSCR)

Oscar Health, Inc. (NYSE:OSCR) was the target of some unusual options trading activity on Wednesday. Traders bought 32,713 call options on the stock. This is an increase of approximately 341% compared to the average daily volume of 7,424 call options.

Analyst Upgrades and Downgrades

Separately, Wells Fargo & Company downgraded shares of Oscar Health from an “overweight” rating to an “equal weight” rating and cut their target price for the stock from $20.00 to $16.00 in a research note on Thursday, March 13th. Two analysts have rated the stock with a sell rating, three have issued a hold rating, two have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $20.21.

Institutional Trading of Oscar Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. grew its stake in Oscar Health by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 18,997,973 shares of the company’s stock worth $255,333,000 after buying an additional 586,626 shares during the last quarter. Deerfield Management Company L.P. Series C increased its position in Oscar Health by 50.7% in the 4th quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company’s stock valued at $159,062,000 after acquiring an additional 3,983,325 shares during the period. JPMorgan Chase & Co. raised its stake in Oscar Health by 348.7% during the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company’s stock valued at $139,246,000 after acquiring an additional 8,051,379 shares during the last quarter. Thrive Capital Management LLC raised its stake in Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock valued at $85,258,000 after acquiring an additional 1,588,395 shares during the last quarter. Finally, Gilder Gagnon Howe & Co. LLC grew its stake in shares of Oscar Health by 51.4% in the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company’s stock valued at $85,154,000 after purchasing an additional 2,151,256 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Stock Up 30.3 %

Shares of Oscar Health stock opened at $17.03 on Thursday. Oscar Health has a 52-week low of $11.20 and a 52-week high of $23.79. The company has a 50 day moving average of $13.27 and a 200 day moving average of $14.62. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The company has a market capitalization of $4.27 billion, a P/E ratio of -850.87 and a beta of 1.75.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, beating analysts’ consensus estimates of $0.83 by $0.09. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The company had revenue of $3 billion for the quarter, compared to analysts’ expectations of $2.87 billion. During the same period last year, the firm earned $0.62 earnings per share. Oscar Health’s quarterly revenue was up 42.2% on a year-over-year basis. As a group, research analysts forecast that Oscar Health will post 0.69 EPS for the current fiscal year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.